Cantor Fitzgerald analyst Olivia Brayer initiated coverage with a Hold rating on Alnylam Pharma (ALNY – Research Report) yesterday and set a ...
Hosted on MSN1mon
Cantor Fitzgerald maintains Vertex stock Overweight ratingTuesday, Cantor Fitzgerald reaffirmed its Overweight ... The firm's analyst, Olivia Brayer, provided insights into the pharmaceutical company's prospects, particularly focusing on the potential ...
Cantor Fitzgerald analyst Olivia Brayer maintained a Buy rating on MannKind (MNKD – Research Report) yesterday and set a price target of $9.00.
Cantor Fitzgerald analyst O. Brayer now expects that the company will earn ($0.70) per share for the year, up from their prior estimate of ($0.72). The consensus estimate for Gossamer Bio’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results